Table 3 Major adverse events
Adverse events | n (%) | |
|---|---|---|
Kidney | Impaired renal function (eGFR < 30 mL/min/1.73 m2) | 25 (51.0%) |
ESKD (dialysis) | 6 (12.2%) | |
Heart | Heart failure (Ejection fraction < 40%) | 8 (16.3%) |
NSTEMI | 2 (4.1%) | |
Brain | Hemorrhage | 0 (0%) |
Infarction | 2 (4.1%) | |
Subarachnoid hemorrhage | 0 (0%) | |
Encephalopathy | 1 (2.0%) | |
Vessels | TMA | 5 (10.2%) |
Eye ground | H0/H1/H2/H3/H4 | 3/ 3/ 2/ 22/ 8 |
Not evaluated | 11 | |